Discover
ALZN
Alzamend Neuro, Inc.
1.12
2 x 0.94
2 x 1.36
bid
ask
-
0.08
6.67%
2 @ 06:13 AM
1.06 -0.06 (5.36%)
| Ytd | -38.46% | |
| 1y | -61.64% |
1.06
day range
1.32
0.84
52 week range
3.60
| Open | 1.32 | Prev Close | 1.20 | Low | 1.06 | High | 1.32 | Mkt Cap | 4.26M |
| Vol | 2.27M | Avg Vol | 146.40K | EPS | -3.67 | P/E | N/A | Forward P/E | -0.26 |
| Beta | -0.04 | Short Ratio | 1.03 | Inst. Own | 0.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-02 | 50-d Avg | 1.14 | 200-d Avg | 1.83 | 1yr Est | 32.00 |
| Income Statement | |||
| Operating Expenses | 2.20M | ||
| Research and Development Expense | 1.28M | ||
| Selling, General and Administrative Expense | 919.03K | ||
| Operating Income | -2.20M | ||
| Interest Expense | 1.34K | ||
| Net Income | -2.20M | ||
| Net Income Common Stock | -2.20M | ||
| Net Income Common Stock (USD) | -2.20M | ||
| Consolidated Income | -2.20M | ||
| Earnings per Basic Share | -0.58 | ||
| Earnings per Basic Share (USD) | -0.58 | ||
| Earnings per Diluted Share | -0.58 | ||
| Earning Before Interest & Taxes (EBIT) | -2.20M | ||
| Earning Before Interest & Taxes (USD) | -2.20M | ||
| Weighted Average Shares | 3.80M | ||
| Weighted Average Shares Diluted | 3.80M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.71M | ||
| Cash and Equivalents (USD) | 2.71M | ||
| Current Assets | 3.70M | ||
| Property, Plant & Equipment Net | 342.55K | ||
| Total Assets | 4.04M | ||
| Current Liabilities | 1.86M | ||
| Total Liabilities | 1.86M | ||
| Accumulated Retained Earnings (Deficit) | -64.44M | ||
| Shareholders Equity | 2.18M | ||
| Shareholders Equity (USD) | 2.18M | ||
| Assets Non-Current | 342.55K | ||
| Trade and Non-Trade Payables | 1.86M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 27.69K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.74M | ||
| Net Cash Flow from Operations | -1.74M | ||
| Share Based Compensation | 9.30K | ||